German Merck Plans To Introduce Child-Friendly Version Of Schistosomiasis Drug For Use In African Donation Program

Reuters: German Merck aims to roll out child formula for schistosomiasis drug
“Merck KGaA said it is developing a children’s formula of its drug to treat schistosomiasis, a parasitic worm disease that infects millions of poor people in Africa and Asia. … The company said it has donated 500 million tablets of praziquantel to the World Health Organization (WHO) over the last 10 years for use in 39 African countries, primarily targeting children who catch the disease in contaminated rivers and lakes. But the pill is large, bitter, and difficult for children to swallow, Belen Garijo, CEO of health care at Merck KGaA, told reporters in Geneva. The new formula will be sweeter…” (Nebehay, 4/18).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.